Filing Details
- Accession Number:
- 0001225208-18-004012
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-23 16:13:44
- Reporting Period:
- 2018-02-21
- Accepted Time:
- 2018-02-23 16:13:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
885725 | Boston Scientific Corp | BSX | Surgical & Medical Instruments & Apparatus (3841) | 042695240 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1529751 | A David Pierce | 300 Boston Scientific Way Marlborough MA 01752-1234 | Svp,Pres Urology,Pelvic Health | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2018-02-21 | 16,286 | $27.00 | 24,201 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2018-02-22 | 2,607 | $0.00 | 26,808 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-02-22 | 1,159 | $26.48 | 25,649 | No | 4 | F | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Deferred Stock Units | Disposition | 2018-02-22 | 2,607 | $0.00 | 2,607 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
7,821 | 2021-02-22 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
- Represents the weighted average sale price. These shares were sold in multiple transactions at $27.00 and $27.005. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.